Resumen
Introduction: Severe asthmatic crises represent a life-threatening medical emergency, characterized by intense dyspnea, wheezing and respiratory compromise. Standard treatment includes oxygen therapy, rapid-acting bronchodilators and systemic corticosteroids; however, in refractory cases, intravenous magnesium sulfate is considered a complementary strategy with bronchodilator effects. Objective: We present the case of a 72-year-old patient with inadequate use of bronchodilators, which triggered a severe asthmatic crisis. Clinical findings: In the absence of response to conventional treatment, intravenous magnesium sulfate was administered, achieving a significant improvement in pulmonary function and oxygenation. Conclusion: This case highlights the usefulness of magnesium sulfate in severe asthmatic crises and the importance of individualized management based on updated guidelines, such as GINA 2023, to optimize treatment and reduce morbidity and mortality in asthmatic patients.
Citas
REFERENCIAS
Cabrera, A., Picado, C., Rodríguez, A., Garcia-Marcos, L. Asthma, rhinitis and eczema symptoms in Quito, Ecuador : a comparative cross-sectional study 16 years after ISAAC. BMJ Open Respir Res. 2021 Sep.; 8(1): e001004. DOI: 10.1136/bmjresp-2021-001004
Boulet, L.P., Reddel, H.K., Bateman, E., Pedersen, S., FitzGerald, J.M., O'Byrne, P.M. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J. 2019, Aug.; 54(2): 1900598. DOI: 10.1183/13993003.00598-2019
Kassisse, E., Jiménez, J., Mayo, N., Kassisse, J. Magnesium sulfate vs aminophylline as a second line of treatment in children with severe acute asthma. Randomized clinical trial. Andes Pediatr. 2021, Jun.; 92(3): 367-374. English, Spanish. DOI: 10.32641/andespediatr.v92i3.2969
Irazuzta, J.E., Chiriboga, N. Magnesium sulfate infusion for acute asthma in the emergency department. J Pediatr (Rio J). 2017, Nov.-Dec.; 93 Suppl 1: 19-25. DOI: 10.1016/j.jped.2017.06.002
Gross Júnior, M., Lago, P.M., Batista Santana, J.C., Biondo, G.F., Zandoná, B., Chiaradia, F.O., et al. Use of magnesium sulfate in continuous infusion in patients with severe acute asthma, in a pediatric emergency room. Pediatr Pulmonol. 2021, Jul.; 56(7): 1924-1930. DOI: 10.1002/ppul.25393
Pruikkonen, H., Tapiainen, T., Kallio, M., Dunder, T., Pokka, T., Uhari, M., Renko, M. Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial. Eur Respir J. 2018, Feb.; 51(2): 1701579. DOI: 10.1183/13993003.01579-2017
Daengsuwan, T., Watanatham, S. A comparative pilot study of the efficacy and safety of nebulized magnesium sulfate and intravenous magnesium sulfate in children with severe acute asthma. Asian Pac J Allergy Immunol. 2017, Jun.; 35(2): 108-112. DOI: 10.12932/AP0780
Javor E., Popovic Grle, S. Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma. Pulm Pharmacol Ther. 2019, Apr.; 55: 31-37. DOI: 10.1016/j.pupt.2019.01.005
Knightly, R., Milan, S.J., Hughes, R., Knopp-Sihota, J.A., Rowe, B.H., Normansell, R., Powell, C. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017, Nov.; 11(11): CD003898. DOI: 10.1002/14651858.CD003898.pub6
Ni, H., Aye, S.Z., Naing, C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022, May; 5(5): CD013506. DOI: 10.1002/14651858.CD013506.pub2
Rovsing AH, Savran O, Ulrik CS. Magnesium sulfate treatment for acute severe asthma in adults-a systematic review and meta-analysis. Front Allergy. 2023, Jul.; 4: 1211949. DOI: 10.3389/falgy.2023.1211949
Johnson, P.N., Drury, A.S., Gupta, N. Continuous Magnesium Sulfate Infusions for Status Asthmaticus in Children: A Systematic Review. Front Pediatr. 2022, Mar.; 10: 853574. DOI: 10.3389/fped.2022.853574
Kwofie, K., Wolfson, A.B. Intravenous Magnesium Sulfate for Acute Asthma Exacerbation in Children and Adults. Am Fam Physician. 2021, Feb. 15; 103(4): 245-246. https://www.aafp.org/pubs/afp/issues/2021/0215/p245.html
Copyright
License
Copyright (c) 2025 Clavijo Rosales, Edison Geovanny, Tamayo Amores, Zamora Cornejo , Juan José Reinoso Calle
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC_SA 4.0) that indicates: a) It is allowed that others share the work, with an acknowledgement of the work's authorship and initial publication in this journal, b) The work may not be used for commercial purposes, c) If it's remixed, transformed, or built upon the material, one must distribute the contributions under the same license as the original
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, website or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
